Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q2- Text added to 2022 Q3
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
AbbVie, adjunctive, biosimilar, cap, cariprazine, catastrophic, dopamine, effectuated, exceeding, excise, geopolitical, heighten, IRA, LIGHTWAVE, monotherapy, monthly, outpace, passage, penalize, Russia, Secretary, stringent, subsidy, threshold, Ukraine, worsen
Removed:
accelerated, addressable, aware, belief, chapter, check, complied, dilution, electronically, emerging, expressed, expressly, filer, harbor, Interactive, mark, Nasdaq, opportunistically, organization, package, par, preceding, registrant, revised, serve, shell, shorter, stated, telephone, terminology, timepoint, transition, view, Washington
Valuein 2022 Q2 filing- Value in 2022 Q3 filing
Original filings
Filing view